[1] |
付 宇, 吴晓敏, 孟庆敏, 等. 食品中沙门菌分布特征及耐药性研究[J]. 中国卫生检验杂志, 2023, 33(2):139-142, 146.FU Y, WU X M, MENG Q M, et al. Research on drug resistance and distribution characteristics of Salmonella in food[J]. Chinese Journal of Health Laboratory Technology, 2023, 33(2):139-142, 146(in Chinese)
|
[2] |
ANSARI N, YAZDIAN-ROBATI R, SHAHDORDIZADEH M, et al. Aptasensors for quantitative detection of Salmonella Typhimurium[J]. Anal Biochem, 2017, 533:18-25.
|
[3] |
GARAI P, GNANADHAS D P, CHAKRAVORTTY D. Salmonella enterica serovars Typhimurium and Typhi as model organisms:revealing paradigm of host-pathogen interactions[J]. Virulence, 2012, 3(4):377-388.
|
[4] |
GAL-MOR O. Persistent infection and long-term carriage of typhoidal and nontyphoidal Salmonellae[J]. Clin Microbiol Rev, 2018, 32(1):e00088-18.
|
[5] |
许敬平, 靳连群, 冯 华, 等. 沙门菌食物中毒的研究进展[J]. 人民军医, 2018, 61(3):274-277.XU J P, JIN L Q, FENG H, et al. Research progress of Salmonella food poisoning[J]. People's Military Surgeon, 2018, 61(3):274-277. (in Chinese)
|
[6] |
BESSER J M. Salmonella epidemiology:a whirlwind of change[J]. Food Microbiol, 2018, 71:55-59.
|
[7] |
CHAUDHARI R, SINGH K, KODGIRE P. Biochemical and molecular mechanisms of antibiotic resistance in Salmonella spp.[J]. Res Microbiol, 2023, 174(1-2):103985.
|
[8] |
GUAN Y, LI Y W, LI J, et al. Phenotypic and genotypic characterization of antimicrobial resistance profiles in Salmonella isolated from waterfowl in 2002-2005 and 2018-2020 in Sichuan, China[J]. Front Microbiol, 2022, 13:987613.
|
[9] |
BUMANN D. Has nature already identified all useful antibacterial targets?[J]. Curr Opin Microbiol, 2008, 11(5):387-392.
|
[10] |
韩雷强. 基于小分子的自组装纳米药物的设计、制备及抗肿瘤活性评价[D]. 济南:山东大学, 2018.HAN L Q. Design, preparation and evaluation of small molecular based nanodrug for cancer therapy[D]. Ji'nan:Shandong University, 2018.
|
[11] |
MARCU L, OLVER I. Tirapazamine:from bench to clinical trials[J]. Curr Clin Pharmacol, 2006, 1(1):71-79.
|
[12] |
SLIWINSKA J, DUDKA J, KORGA A, et al. Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca2+ balance protein levels[J]. Oxid Med Cell Longev, 2012, 2012:890826.
|
[13] |
SHAH Z, MAHBUBA R, TURCOTTE B. The anticancer drug tirapazamine has antimicrobial activity against Escherichia coli, Staphylococcus aureus and Clostridium difficile[J]. Fems Microbiol Lett, 2013, 347(1):61-69.
|
[14] |
LI Q, LIU Y M, GUO X P, et al. Tirapazamine-loaded CalliSpheres microspheres enhance synergy between tirapazamine and embolization against liver cancer in an animal model[J]. Biomed Pharmacother, 2022, 151:113123.
|
[15] |
AJNAI G, CHENG C C, KAN T C, et al. Improving tirapazamine (TPZ) to target and eradicate hypoxia tumors by gold nanoparticle carriers[J]. Pharmaceutics, 2022, 14(4):847.
|
[16] |
中华人民共和国国家卫生和计划生育委员会, 国家食品药品监督管理总局. GB 4789. 4-2016 食品安全国家标准 食品微生物学检验 沙门氏菌检验[S]. 北京:中国标准出版社, 2017.National Health and Family Planning Commission of PRC, China Food and Drug Administration. GB 4789. 4-2016 Microbiological examination of foodhygiene-Examination of Salmonella[S]. Beijing:Standards Press of China, 2017(in Chinese)
|
[17] |
SIVARANJANI M, PRAKASH M, GOWRISHANKAR S, et al. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms[J]. Appl Microbiol Biotechnol, 2017, 101(8):3349-3359.
|
[18] |
DRAUCH V, IBESICH C, VOGL C, et al. In-vitro testing of bacteriostatic and bactericidal efficacy of commercial disinfectants against Salmonella Infantis reveals substantial differences between products and bacterial strains[J]. Int J Food Microbiol, 2020, 328:108660.
|
[19] |
HANEY E F, TRIMBLE M J, CHENG J T, et al. Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides[J]. Biomolecules, 2018, 8(2):29.
|
[20] |
KROM B P, COHEN J B, MCELHANEY FESER G E, et al. Optimized candidal biofilm microtiter assay[J]. J Microbiol Methods, 2007, 68(2):421-423.
|
[21] |
CHOUSALKAR K, GAST R, MARTELLI F, et al. Review of egg-related salmonellosis and reduction strategies in United States, Australia, United Kingdom and New Zealand[J]. Crit Rev Microbiol, 2018, 44(3):290-303.
|
[22] |
KNODLER L A, ELFENBEIN J R. Salmonella enterica[J] Trends Microbiol, 2019, 27(11):964-965.
|
[23] |
李 宁, 白 莉. 中美欧食源性细菌耐药性监测系统比较研究及启示[J]. 食品科学技术学报, 2023, 41(1):1-9, 21.LI N, BAI L. Comparative study on foodborne bacterial antimicrobial resistance surveillance system in China, America and Europe and its implication[J]. Journal of Food Science and Technology, 2023, 41(1):1-9, 21. (in Chinese)
|
[24] |
CHEN Z Q, BAI J, WANG S J, et al. Prevalence, antimicrobial resistance, virulence genes and genetic diversity of Salmonella isolated from retail duck meat in southern China[J]. Microorganisms, 2020, 8(3):444.
|
[25] |
ZHANG Q Q, YING G G, PAN C G, et al. Comprehensive evaluation of antibiotics emission and fate in the river basins of China:source analysis, multimedia modeling, and linkage to bacterial resistance[J]. Environ Sci Technol, 2015, 49(11):6772-6782.
|
[26] |
KLEIN E Y, VAN BOECKEL T P, MARTINEZ E M, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015[J]. Proc Natl Acad Sci U S A, 2018, 115(15):E3463-E3470.
|
[27] |
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019:a systematic analysis[J]. Lancet, 2022, 399(10325):629-655.
|
[28] |
VESTBY L K, GRØNSETH T, SIMM R, et al. Bacterial biofilm and its role in the pathogenesis of disease[J]. Antibiotics (Basel), 2020, 9(2):59.
|
[29] |
SHARMA G, SHARMA S, SHARMA P, et al. Escherichia coli biofilm:development and therapeutic strategies[J]. J Appl Microbiol, 2016, 121(2):309-319.
|
[30] |
LISTER J L, HORSWILL A R. Staphylococcus aureus biofilms:recent developments in biofilm dispersal[J]. Front Cell Infect Microbiol, 2014, 4:178.
|
[31] |
VAN WOLFEREN M, ORELL A, ALBERS S V. Archaeal biofilm formation[J]. Nat Rev Microbiol, 2018, 16(11):699-713.
|
[32] |
HALL C W, MAH T F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria[J]. FEMS Microbiol Rev, 2017, 41(3):276-301.
|